Correlation Between Aclaris Therapeutics and IDEXX Laboratories

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and IDEXX Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and IDEXX Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and IDEXX Laboratories, you can compare the effects of market volatilities on Aclaris Therapeutics and IDEXX Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of IDEXX Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and IDEXX Laboratories.

Diversification Opportunities for Aclaris Therapeutics and IDEXX Laboratories

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aclaris and IDEXX is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and IDEXX Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IDEXX Laboratories and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with IDEXX Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IDEXX Laboratories has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and IDEXX Laboratories go up and down completely randomly.

Pair Corralation between Aclaris Therapeutics and IDEXX Laboratories

Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 3.8 times more return on investment than IDEXX Laboratories. However, Aclaris Therapeutics is 3.8 times more volatile than IDEXX Laboratories. It trades about 0.02 of its potential returns per unit of risk. IDEXX Laboratories is currently generating about 0.01 per unit of risk. If you would invest  1,565  in Aclaris Therapeutics on August 24, 2024 and sell it today you would lose (1,133) from holding Aclaris Therapeutics or give up 72.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Aclaris Therapeutics  vs.  IDEXX Laboratories

 Performance 
       Timeline  
Aclaris Therapeutics 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Aclaris Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Aclaris Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
IDEXX Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IDEXX Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Aclaris Therapeutics and IDEXX Laboratories Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aclaris Therapeutics and IDEXX Laboratories

The main advantage of trading using opposite Aclaris Therapeutics and IDEXX Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, IDEXX Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IDEXX Laboratories will offset losses from the drop in IDEXX Laboratories' long position.
The idea behind Aclaris Therapeutics and IDEXX Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stocks Directory
Find actively traded stocks across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets